The anticancer drug perillyl alcohol is a Na/K-ATPase inhibitor
Tóm tắt
The monoterpene perillyl alcohol (POH) is a drug used in the treatment of several malignant tumors, including gliomas. The present study defines a POH inhibitory effect on Na/K-ATPase activity from kidney and brain guinea pig extracts and from a human glioblastoma cell line. This inhibition showed a high degree of selectivity toward the kidney enzyme expressing, as do glioblastoma cells, the α1 subunit. Kinetic studies with purified enzymes showed a noncompetitive POH inhibition profile to Na+ and K+ and an uncompetitive inhibition towards ATP. Furthermore, potassium activated p-nitrophenylphosfatase activity of these purified preparations was not inhibited by POH, suggesting that this drug, differently from the classical inhibitor ouabain, acted in the initial phase of the enzyme’s catalytic cycle. We suggest that POH antitumor action could be linked to its Na/K-ATPase binding properties.
Tài liệu tham khảo
Skou JC (1957) The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim Biophys Acta 23:394–401
Skou JC (1998) The identification of the sodium pump. Biosci Rep 18:155–169
Aperia A (2007) New roles for an old enzyme: Na, K-ATPase emerges as an interesting drug target. J Intern Med 261:44–52
Jaitovich AA, Bertorello AM (2006) Na+, K+-ATPase: an indispensable ion pumping-signaling mechanism across mammalian cell membranes. Semin Nephrol 26:386–392
Yu SP (2003) Na(+), K(+)-ATPase: the new face of an old player in pathogenesis and apoptotic/hybrid cell death. Biochem Pharmacol 66:1601–1609
Chen JQ, Contreras RG, Wang R, Fernandez SV, Shoshani L, Russo IH, Cereijido M, Russo J (2006) Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: a new paradigm for development of anti-breast cancer drugs? Breast Cancer Res Treat 96:1–15
Dickey CA, Gordon MN, Wilcock DM, Herber DL, Freeman MJ, Morgan D (2005) Dysregulation of Na+/K+ ATPase by amyloid in APP + PS1 transgenic mice. BMC Neurosci 6:7
Tsimarato M, Coste TC, Djemli-Shipkolye A, Daniel L, Shipkolye F, Vague P, Raccah D (2001) Evidence of time-dependent changes in renal medullary Na, K-ATPase activity and expression in diabetic rats. Cell Mol Biol (Noisy-le-grand) 47:239–245
Liu X, Songu-Mize E (1997) Alterations in alpha subunit expression of cardiac Na+, K+-ATPase in spontaneously hypertensive rats: effect of antihypertensive therapy. Eur J Pharmacol 327:151–156
Burth P, Younes-Ibrahim M, Goncalez FH, Costa ER, Faria MV (1997) Purification and characterization of a Na+, K+ ATPase inhibitor found in an endotoxin of Leptospira interrogans. Infect Immun 65:1557–1560
Stenkvist B (1999) Is digitalis a therapy for breast carcinoma? Oncol Rep 6:493–496
Kometiani P, Liu L, Askari A (2005) Digitalis-induced signaling by Na+/K+-ATPase in human breast cancer cells. Mol Pharmacol 67:929–936
Lefranc F, Kiss R (2008) The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas. Neoplasia 10:198–206
Lefranc F, Mijatovic T, Kondo Y, Sauvage S, Roland I, Debeir O, Krstic D, Vasic V, Gailly P, Kondo S, Blanco G, Kiss R (2008) Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells. Neurosurgery 62:211–221 discussion 221–222
Mijatovic T, Van Quaquebeke E, Delest B, Debeir O, Darro F, Kiss R (2007) Cardiotonic steroids on the road to anti-cancer therapy. Biochim Biophys Acta 1776:32–57
Winnick K, Bielawski K, Bielawski A (2006) Cardiac glycosides in cancer research and cancer therapy. Acta Pol Pharm 63:109–115
Mijatovic T, Ingrassia L, Facchini V, Kiss R (2008) Na+/K+-ATPase alpha subunits as new targets in anticancer therapy. Expert Opin Ther Targets 12:1403–1417
Sakai H, Suzuki T, Maeda M, Takahashi Y, Horikawa N, Minamimura T, Tsukada K, Takeguchi N (2004) Up-regulation of Na(+), K(+)-ATPase alpha 3-isoform and down-regulation of the alpha1-isoform in human colorectal cancer. FEBS Lett 563:151–154
Holstein SA, Hohl RJ (2003) Monoterpene regulation of Ras and Ras-related protein expression. J Lipid Res 44:1209–1215
Fernandes J, da Fonseca CO, Teixeira A, Gattass CR (2005) Perillyl alcohol induces apoptosis in human glioblastoma multiforme cells. Oncol Rep 13:943–947
Xu M, Floyd HS, Greth SM, Chang WL, Lohman K, Stoyanova R, Kucera GL, Kute TE, Willingham MC, Miller MS (2004) Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects. Toxicol Applied Pharmacol 195:232–246
Yeruva L, Pierre KJ, Elegbede A, Wang RC, Carper SW (2007) Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells. Cancer Lett 257:216–226
Da Fonseca CO, Landeiro JA, Clark SS, Quirico-Santos T, da Costa Carvalho Mda G, Gattass CR (2006) Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol. Surg Neurol 65(suppl 1):S1:2–1:8 (discussion S1:8–1:9)
Da Fonseca CO, Silva JT, Lins IR, Simao M, Arnobio A, Futuro D, Quirico-Santos T (2009) Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol. Invest New Drugs 27:557–564
Jorgensen PL (1977) Purification and characterization of (Na+ + K+)-ATPase. VI. Differential tryptic modification of catalytic functions of the purified enzyme in presence of NaCl and KCl. Biochim Biophys Acta 466:97–108
Gill S, Gill R, Wicks D, Despotovski S, Liang D (2004) Development of an HTS assay for Na + , K + -ATPase using nonradioactive rubidium ion uptake. Assay Drug Dev Technol 2:535–542
Dos Santos Mda C, Burth P, Younes-Ibrahim M, Goncalves CF, Santelli RE, Oliveira EP, de Castro Faria MV (2009) Na/K-ATPase assay in the intact guinea pig liver submitted to in situ perfusion. Anal Biochem 385:65–68
Rodriguez de Lores Arnaiz G, Herbin T, Pena C (2003) A comparative study between a brain Na+, K(+)-ATPase inhibitor (endobain E) and ascorbic acid. Neurochem Res 28:903–910
Garcia DG, Bianco EM, Santos Mda C, Pereira RC, Faria MV, Teixeira VL, Burth P (2009) Inhibition of mammal Na(+) K(+)-ATPase by diterpenes extracted from the Brazilian brown alga Dictyota cervicornis. Phytother Res 23:943–947
Azzoli CG, Miller VA, Ng KK, Krug LM, Spriggs DR, Tong WP, Riedel ER, Kris MG (2003) A phase I trial of perillyl alcohol in patients with advanced solid tumors. Cancer Chemother Pharmacol 51:493–498
Balassiano IT, De Paulo SA, Silva NH, Cabral MC, Gibaldi D, Bozza M, Da Fonseca CO, Carvalho MGC (2002) Effects of perillyl alcohol in glial C6 cell line in vitro and anti-metastatic activity in chorioallantoic membrane model. Intern J Mol Med 10:785–788
Hohl RJ, Lewis K (1995) Differential effects of monoterpenes and lovastatin on RAS processing. J Biol Chem 270:17508–17512
Stayrook KR, McKinzie JH, Barbhaiya LH, Crowell PL (1998) Effects of the antitumor agent perillyl alcohol on H-Ras versus K-Ras farnesylation and signal transduction in pancreatic cells. Anticancer Res 18:823–828
Kulikov A, Eva A, Kirch U, Boldyrev A, Scheiner-Bobis G (2007) Ouabain activates signaling pathways associated with cell death in human neuroblastoma. Biochim Biophys Acta 1768:1691–1702
Prassas I, Diamandis EP (2008) Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov 7:926–935
Xie Z, Cai T (2003) Na/K ATPase mediated signal transduction: from protein interaction to cellular function. Mol Interv 3:157–164
Lopez-Lazaro M, Pastor N, Azrak SS, Ayuso MJ, Austin CA, Cortes F (2005) Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients. J Nat Prod 68:1642–1645
Bailey HH, Wilding G, Tutsch KD, Arzoomanian RZ, Alberti D, Feierabend C, Simon K, Marnocha R, Holstein SA, Stewart J, Lewis KA, Hohl RJ (2004) A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days. Cancer Chemother Pharmacol 54:368–376
Wang H, Haas M, Liang M, Cai T, Tian J, Li S, Xie Z (2004) Ouabain assembles signaling cascades through the caveolar Na+/K+-ATPase. J Biol Chem 279:17250–17259